Vinay Vyas - Concepedia

Author

Vinay Vyas

Science Applications International Corporation (United States)

Also Known As

V. V. Vyas, V. Vyas, V.V Vyas, V.V. Vyas, VISHWA VYAS, Vidhi vyas, Vinay V. Vyas, Vinay Vyas

Publications

454

Citations

H-Index

Concepts

All Affiliations

Science Applications International Corporation (United States)Frederick National Laboratory for Cancer Research National Cancer Institute Center for Cancer Research Protein Express (United States)

About

Vinay Vyas is an author at Science Applications International Corporation (United States) specializing in medicine, immunology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	345
2	Biochemistry	2	2	27
3	Natural Sciences	1	1	13
4	Allergy	1	1	38
5	Biomolecular Engineering	1	1	13

Vinay Vyas

Publications

419

Citations

H-Index

Page 1

	Year	Citations
IL-15:IL-15 receptor alpha superagonist complex: High-level co-expression in recombinant mammalian cells, purification and characterization Kaiping Han, Xiaoyun Zhu, Bai Liu, Cytokine InflammationCytokineImmune RegulationImmunologyImmunologic Mechanism	2011	216
MTS dye based colorimetric CTLL-2 cell proliferation assay for product release and stability monitoring of Interleukin-15: Assay qualification, standardization and statistical analysis Gopalan Soman, Xiaoyi Yang, Hengguang Jiang, Journal of Immunological Methods InflammationCytokineAllergyLaboratory ImmunologyProduct Release	2009	38
Effect of growth environment on the stability of a recombinant shuttle plasmid, pCPPS-31, in Escherichia coli Reena Gupta, Prince Sharma, Vinay Vyas Journal of Biotechnology BacteriologyBiotechnologyEscherichia ColiGrowth EnvironmentMicrobial Physiology	1995	35
Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague Jeremy L. Goodin, David F. Nellis, Bradford S. Powell, Protein Expression and Purification VaccinationCross-protectionProtective EfficacyVaccine DevelopmentVaccine Target	2007	26
Clinical manufacturing of recombinant human interleukin 15. I. Production cell line development and protein expression in <i>E. coli</i> with stop codon optimization Vinay Vyas, Dominic Esposito, Terry L. Sumpter, Biotechnology Progress	2011	20
Characterization of Recombinant Human IL-15 Deamidation and Its Practical Elimination through Substitution of Asparagine 77 David F. Nellis, Dennis F. Michiel, Man‐Shiow Jiang, Pharmaceutical Research CytokineAutoimmune DiseaseMedicineImmunodeficienciesImmunology	2011	17
NMR Structure of the Natural Killer Cell Receptor 2B4 (CD244): Implications for Ligand Recognition<sup>,</sup> James B. Ames, Vinay Vyas, Jacqueline D. Lusin, Biochemistry	2005	14
Activation of enzymes by reversed micelles R. C. Srivastava, Datta Madamwar, Vinay Vyas Biotechnology and Bioengineering BiochemistryEnzyme CatalysisMicelleEnzymatic ModificationReversed Micelles	1987	14
Entropically Assisted Carbohydrate Recognition by a Natural Killer Cell‐Surface Receptor Chittoor P. Swaminathan, Neelowfar Wais, Vinay Vyas, ChemBioChem Favorable Enthalpic ContributionsBiochemistryNatural SciencesSialooligosaccharide RecognitionGlycobiology	2004	13
Identification of vacancy defects in carbon nanotubes using vibration analysis and machine learning Sneha Singh, Zaid Bin Junaid, Vinay Vyas, Carbon Trends	2021	13

Page 1